India's Gland Pharma to make up to 252 million Sputnik V vaccine doses

Sputnik V, developed by Moscow's Gamaleya Institute, has been approved in 22 countries, with the RDIF signing supply deals with over 13 countries.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news